While GLP-1s are highly effective and drive profound health impacts, low rates of adherence mean employers and health plans are increasingly stuck with rising GLP-1 costs, but without the intended health outcomes and savings
At that time, Natures Sunshine had no illusions about their brand predicament
September 15, 2022
Bone resorption is unchanged by liraglutide in type 2 diabetes patients: A randomised controlled trial
5a) design through systematic optimization, conjugating ER-targeting PROTACs to anti-HER2 antibodies and demonstrating that modulation of linker composition and attachment sites enhances in vivo stability [218,219,220]
Whilst systemic corticosteroids and conventional immunomodulators have been the primary therapeutic agents, evolving strategies, including biologics and small molecules targeting tumour necrosis factor, different cytokines, or Janus kinase signalling pathways, signify a shift towards a precision management paradigm that considers individual clinical presentations